Mithra grants Fuji commercialization rights to Donesta in Asia

Mithra Pharmaceuticals S.A. (Euronext:MITRA) granted Fuji Pharma Co. Ltd. (Tokyo:4554) exclusive rights to commercialize Donesta in Japan and in the Association of Southeast Asian Nations (ASEAN). The orally-administered estetrol is in Phase II to treat vasomotor menopause symptoms, with top-line data expected 1Q18...